Chiral Inversion of Thalidomide During Crystal Growth by Sublimation
- 3 April 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 24 (8) , 3133-3139
Abstract
No abstract availableFunding Information
- Japan Society for the Promotion of Science (23K04812)
This publication has 35 references indexed in Scilit:
- Enantiomerization Mechanism of Thalidomide and the Role of Water and Hydroxide IonsChemistry – A European Journal, 2012
- Synthesis, configurational stability and stereochemical biological evaluations of (S)- and (R)-5-hydroxythalidomidesBioorganic & Medicinal Chemistry Letters, 2009
- Synthesis of Thalidomide2007
- The unified equation for the evaluation of degenerated first‐order reactions in dynamic electrophoresisElectrophoresis, 2006
- RIKEN structural genomics beamlines at the SPring-8; high throughput protein crystallography with automated beamline operationJournal of Structural and Functional Genomics, 2006
- Gaseous Ion Activation Dynamics: The Role of the Bulk Gas in the Racemization of Chiral Oxonium IonsChemphyschem, 2004
- Gas‐Phase Activation and Reaction Dynamics of Chiral Ion–Dipole ComplexesChemistry – A European Journal, 2003
- Determination of the enantiomerization barrier of thalidomide by dynamic capillary electrokinetic chromatographyElectrophoresis, 2001
- Investigations on the in vitro racemization of thalidomide by high-performance liquid chromatographyJournal of Chromatography A, 1994
- Synthesis of D- and L-Thalidomide and Related StudiesJournal of Pharmaceutical Sciences, 1968